Shareholding21 Jul 2026, 05:40 pm

Gujarat Themis Biosyn: Promoter Group Indirectly Encumbers 47.02% Stake

AI Summary

Gujarat Themis Biosyn Limited (GTBL) has reported an indirect encumbrance on 47.02% of its equity share capital, held by its promoter group entity, Pharmaceutical Business Group (India) Limited (PBGIL). This encumbrance arises from a pledge of 25,24,245 equity shares (51% of PBGIL's capital) and a non-disposal undertaking over 21,57,855 equity shares (47.98% of PBGIL's capital) by Vividhmargi Investments Private Limited (VIPL) in favor of CTL Trusteeship Limited. The encumbrance is in connection with debentures issued by PBGIL. This disclosure is made under SEBI (SAST) Regulations, 2011.

Key Highlights

Promoter group entity PBGIL has indirectly encumbered 47.02% of GTBL shares.
Encumbrance involves a pledge and non-disposal undertaking on PBGIL's shares.
The move is related to debenture financing for PBGIL.
Disclosure made as per SEBI (SAST) Regulations, 2011.

View BSE Filing

GUJTHEM

Pharmaceuticals

GUJARAT THEMIS BIOSYN LTD.

Price Impact